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Abstract  
Foodborne pathogens are a major concern to the food industry and 
consumers but they may be controlled with antimicrobials. Naturally occurring 
antimicrobials may be isolated from a variety of plant, animal and microbial 
sources. Previous studies have demonstrated that peptides isolated from 
enzyme hydrolyzed milk proteins may have in vivo and in vitro antimicrobial 
activity. Such compounds could be of use as inhibitors of foodborne pathogens. 
The objectives of this study were to determine the antimicrobial effectiveness 
against Salmonella Typhimurium and Listeria monocytogenes of digests of 
bovine acid-precipitated casein with the enzymes pepsin and trypsin and to 
determine if these peptides were effective in combination with 
ethylendiaminetetraacetic acid (EDTA) and sodium lactate against these 
foodborne pathogens.  
Whole casein was precipitated from fresh, unpasteurized skimmed cow’s 
milk by addition of 2 N HCl. Precipitated casein was separated by centrifugation, 
washed and lyophilized. Rehydrated casein was hydrolyzed with either pepsin or 
trypsin and the reaction mixture was heated to inactivate each enzyme. 
For method 1, solutions with hydrolyzed protein were dialyzed against 
water and freeze-dried. For method 2, 5.0% casein was dissolved in buffer and 
treated similarly to method 1, however the peptides that were created from 
enzymatic hydrolysis were separated by centrifugation after inactivation of the 
enzymes by heat and were not dialyzed against water. For both methods, 
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hydrolysates created were adjusted to pH 7 and filter sterilized through a 0.45 µm 
membrane filter  
The inhibitory effect of filtered pepsin and trypsin hydrolysates (0.5% and 
1.0%) (method 1) and filtered supernate (pepsin and trypsin) (method 2) alone 
and in combination with EDTA and sodium lactate against four strains each of L. 
monocytogenes and S. Typhimurium DT104 was determined. Growth was 
monitored over 24 hours using a microbroth dilution assay for all hydrolysates. 
Growth curves were used to relate microtiter data to actual colony counts.  
For method 1, pepsin hydrolysates were not very effective in inhibiting the 
growth of any of the four strains of S. Typhimurium or L. monocytogenes while 
trypsin hydrolysates were only slightly effective at extending the lag phase and/or 
reducing the final growth level of all four strains of L. monocytogenes. This 
ineffectiveness was most likely due to the loss of small molecular weight peptides 
during the dialysis step. The addition of EDTA had little effect in enhancing the 
inhibitory effect of pepsin or trypsin hydrolysates against either microorganism.  
For method 2, trypsin hydrolysates were effective in extending the lag 
phase and/or reducing the final growth level of all four strains of L. 
monocytogenes tested; however, they were not effective against any of the 
strains of S. Typhimurium. Pepsin hydrolysate was not effective in extending the 
lag phase or reducing the final growth level in S. Typhimurium. However, pepsin 
did reduce the final growth level of one strain of L. monocytogenes, 101. Trypsin 
and pepsin hydrolysates derived from bovine milk in combination with EDTA and 
sodium lactate had antimicrobial activity against both L. monocytogenes and S. 
v 
Typhimurium in tryptic soy broth (TSB). Trypsin hydrolysates also enhanced the 
antimicrobial activity of sodium lactate against Listeria monocytogenes.  
The protein concentrations of pepsin and trypsin hydrolysates (before and 
after membrane filtration) prepared using method 2 was determined with three 
different protein assays, Bradford dye-binding, modified Lowry and UV 280 nm. 
For all three methods, non-filtered hydrolysates were higher in protein 
concentration than those that were filtered. Using the Bradford method, pepsin 
hydrolysates were higher in protein concentration than trypsin hydrolysates in 
both filtered and non-filtered samples. The opposite results were observed when 
using both modified Lowry method and UV 280 nm method to determine protein 
concentration. By examining the location of the peptide bond hydrolysis of the 
enzymes, it was possible to determine that small molecular weight peptides were 
created by the addition of trypsin and pepsin to bovine casein. Variation in 
number of amino acids as well as types of amino acids of peptides created 
during hydrolysis likely influenced the antimicrobial effectiveness of each 
hydrolysate.    
Casein-derived peptides could provide an alternative or adjunct to 
antimicrobials currently used in foods. It is suggested that antimicrobial peptides 
can be created by enzymatic hydrolysis of casein with trypsin and these peptides 
have the potential to serve as antimicrobials in food systems. Further research 
needs to be conducted in enhancing the activity by concentrating the 
hydrolysates or isolating and characterizing those peptides with the greatest 
antimicrobial potential. 
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1. Introduction 
Foodborne pathogens are a major concern in the food industry. 
Consumers are at risk for the harmful effects caused by many foodborne 
pathogenic bacteria, including Salmonella Typhimirium and Listeria 
monocytogenes. There are numerous methods of inhibiting or inactivating 
microorganisms in foods including, but not limited to, heating, refrigeration, 
freezing, dehydration, addition of sugars, salts or acids, fermentation, smoking, 
and the use of alternative packaging (Potter and Hotchkiss 1998). However, 
another means of inhibiting the growth of foodborne pathogens is through the 
use of chemical antimicrobials. One of the major drawbacks to the use of 
regulatory-approved traditional antimicrobials is their lack of activity in foods with 
pH less than 5.0. This limits their usefulness to control pathogens in most low 
acid foods. In addition, food processors are interested in so-called “natural” or 
bio-based compounds, such as those derived from animal products and plants, 
as antimicrobials because they perceive that consumers are interested in a 
reduction in the use of such preservatives (Dufour et al. 2002).  
Milk is not only nutritionally beneficial, but is known to possess bioactive 
compounds that may reduce or prevent bacterial growth. Casein, the main 
protein found in milk, is a good source of such peptides/protein fragments that 
have certain physiological functions such as aiding in gastrointestinal function 
and digestion, hemodynamic modulation (antihypertension and increased blood 
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flow), probiotic support of gut microflora, non-immune disease protection, passive 
immunity, immunoregulation, anti-inflammation, growth and development (Tome 
and Debabbi 1998; Schanbacher et al. 1997). Biologically active peptides have 
been obtained in vitro by proteolysis (Bellamy et al. 1992; Zucht et al. 1995; 
Recio and Visser 1999) and in vivo by gastric digestion of milk proteins (Kuwata 
et al. 1998; Meisel and Bockelmann 1999). Bioactive peptides derived from milk 
with specific antimicrobial properties, released from protein hydrolysis, have been 
found in milk protein hydrolysates, including those with opioid, antihypertensive 
and antithrombic properties (Schlimme and Meisel 1995; Korhonen et al. 1998; 
Clare and Swaisgood 2000; Pihlanto-Leppala 2001).   
Hydrolysis of the milk components, lactoferrin (Kimura et al. 2000; Kuwata 
et al. 1998; Nibbering et al. 2001; Groenink et al. 1999; Branen and Davidson 
2000; Qian et al. 1995), bovine hemoglobin (Froidevaux et al. 2001), casein 
(Liepke et al. 2001; Lahov and Regelson 1996; Recio and Visser 1999), α-
lactoalbumin (Pellegrini et al. 1999), α-lactoglobulin (Pellegrini et al. 2001) and 
whey (Pihlanto-Leppala 2001) produce hydrolysates with antimicrobial activity. 
Known fragments of bovine casein with antimicrobial activity are isracedin (Hill et 
al. 1974), casocidin-I (Zucht et al. 1995), α-casecidins (Otani and Suzuki 2003), 
kappacin (Malkoski et al. 2001), and the κ-casein-derived glycomacropeptide 
(Stromqvist et al. 1995; Aniansson et al. 1990).  
The objectives of this study were to: (1) determine the antimicrobial 
effectiveness against Salmonella Typhimurium and Listeria monocytogenes of 
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digests of bovine acid-precipitated casein with the enzymes pepsin and trypsin 
and (2) if these hydrolysates were effective in combination with 
ethylenediaminetetraacetic acid (EDTA) and sodium lactate against these 
foodborne pathogens.  
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2. Literature Review 
2.1 Listeria monocytogenes 
2.1.1 Characteristics of the Organism 
Listeria monocytogenes was first identified in animals in 1911 and in 
humans in 1929; however, it is only within the last twenty years that the 
microorganism was recognized as a foodborne pathogen. It has increased 
importance among the foodborne pathogens because of its ability to grow at 
refrigeration temperatures (FDA 2004). 
L.  monocytogenes is a small Gram-positive, non-spore-forming, non-acid-
fast rod. Listeria species have been found in a wide range of environments, have 
tolerances to stresses such as low pH and high NaCl concentrations (10-12%) 
and can grow over large temperature (0-45oC) and pH (4.4 to 9.6) ranges. 
Listeria are injured by heating to 50oC and above (Swaminathan 2001). Tryptose 
broth with up to 0.1% acetic, citric, or lactic acids has been found to inhibit the 
growth of L. monocytogenes (Ahamad and Marth 1989). Frozen storage and 
freezing affect the inactivation and injury of L. monocytogenes differently 
depending on the rate of freezing and type of substrate (Swaminathan 2001). L. 
monocytogenes is a facultative anaerobe that is not greatly affected by vacuum 
packaging (Swaminathan 2001). Resistance of the microorganism to such 
environments, in combination with its ability to colonize and grow in harsh 
conditions, makes L. monocytogenes a major threat to consumers and the food 
industry (Fenlon 1999).  
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2.1.2 Sources of Food Contamination 
L. monocytogenes is widely distributed and is commonly found in the soil 
and water as well as on decaying plant material; however, there are low numbers 
of organisms present in most environments (Fenlon 1999). L. monocytogenes 
has also been found in the feces of a wide range of healthy animal species 
including sheep, goats and cattle (Fenlon1999). Humans can be symptomatic 
and asymptomatic carriers (Fenlon 1999).  
Listeria can enter a food processing facility in a number of ways including, 
on the shoes and clothing of workers, on transportation equipment, through 
contaminated animal hides, on raw foods or by way of human carriers.  
Processing environments, such as drains and floors, with high humidity and 
nutrient sources favor the growth of Listeria (Swaminathan 2001; Rocourt and 
Cossart 1997).  
Foods that are at highest risk for causing listeriosis are ready-to-eat (RTE) 
and stored at refrigeration temperatures for long periods, such as deli meats and 
hot dogs, and dairy foods using unpasteurized milk, such as some soft cheeses 
(Swaminathan 2001; Rocourt and Cossart 1997). These foods may be 
contaminated with high populations of the bacteria (>100 CFU/g or ml). In a 
survey of retail vacuum-packaged meat samples, 53% tested were contaminated 
with L. monocytogenes (Grau and Vanderlinde 1992). L. monocytogenes can 
survive for long periods on foods and in food processing environments and can 
be found on both raw and processed foods. Ice cream, raw and cooked chicken, 
raw vegetables, and raw and smoked fish have all been associated with 
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infection. An important mode of transmission is post-processing contamination 
where RTE foods are contaminated after processing (Swaminathan 2001; 
Rocourt and Cossart 1997). 
2.1.3 Epidemiology of Disease 
According to the Centers for Disease Control (CDC), L. monocytogenes 
causes 2500 cases and 500 deaths annually (2003). The first documented 
outbreak of foodborne listeriosis occurred in Canada in 1981 and was traced to 
the consumption of contaminated coleslaw. The coleslaw, which was fertilized 
with sheep manure, was thought the most possible source of Listeria 
contamination (Rocourt and Cossart 1997). The largest outbreak in the US was 
in California in 1985 and implicated L. monocytogenes 4b in a Mexican style 
cheese called queso blanco. There were 142 cases and 48 deaths in the 
outbreak. The cause was theorized to be due to use of raw milk in the cheese 
and/or general contamination of the processing plant and workers (CDC 2004). 
The consumption of contaminated turkey meat resulted in 54 illnesses, 8 deaths, 
and 3 fetal deaths in 9 states in 2002 (CDC 2003). A majority of listeriosis cases 
are sporadic and difficult to link epidemiologically (FDA 2004) while the annual 
incidence of listeriosis has decreased by 38% from 1996 to 2002 (CDC 2003)., 
outbreaks continue to occur.  
When ingested, L. monocytogenes colonizes the intestinal tract, invades 
the tissues and enters the blood stream. Listeriolysin O (LLO), a secreted protein 
of 58-60 kDa belonging to the family of pore-forming, sulfhydryl-activated 
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cytolysins, has been identified as the substance responsible for beta-hemolysis 
of erythrocytes and the engulfment and destruction of phagocytic cells (Kuhn and 
Goebel 1999). LLO is very similar to streptolysin O (SLO), its prototype produced 
by Streptococcus pyogenes. LLO and SLO are only active on membranes 
containing cholesterol. Listeria enters the phagocytes either directly into the 
phagosomes or from the phagosomes into the phagocytic cytoplasm. Listeria are 
internalized in membrane-bound vacuoles, which are then lysed within 30 min. 
LLO is the main factor in the lysis of the vacuole. The intracellular bacteria are 
released into the cytosol and begin to multiply. LLO assists L. monocytogenes 
once inside macrophages by aiding in their escape from the phagolysosomal 
membranes into the cytosol. Once in the cytosol, ActA, a 610 amino acid surface 
protein anchored to the bacterial cytoplasmic membrane, facilitates the 
production of actin tails which provide the organisms the ability to move toward 
the cytoplasmic membrane (Swaminathan 2001; Rocourt and Cossart 1997). The 
bacteria become covered with cell actin filaments which rearrange into a “comet 
tail”, composed of actin microfilaments that are continuously assembled and left 
behind in the cytosol by moving bacteria. At the plasma membrane, the bacteria 
form protrusions with a bacterium at the tip. The protrusions are internalized by a 
neighboring cell, forming a two-membrane-bound vacuole. Lysis of this new 
vacuole starts a new cycle of replication, movement and spreading of bacteria 
(Swaminathan 2001; Rocourt and Cossart 1997). 
Listeriosis is the disease caused by L. monocytogenes. Healthy 
individuals, that are neither immuno-compromised nor pregnant, are highly 
8 
resistant to contracting listeriosis. At risk groups for disease include the elderly, 
pregnant women and the immuno-compromised. AIDS patients are nearly 300 
times more likely to develop the disease than those individuals with a normal 
immune system. Healthy children and adults occasionally develop listeriosis; 
however, the illness is not usually severe. The infectious dose is believed to be 
more than 100 CFU/ml (Swaminathan 2001). Onset of symptoms for serious 
forms of the infection can be from a few days up to three weeks. The most 
common symptoms of listeriosis are meningitis and sepsis with mortality rates of 
20 to 25% (Swaminathan 2001). Pregnant females typically develop the disease 
in the third trimester but may not show any signs or very mild signs such as flu-
like symptoms. Pregnant females contracting the disease can deliver 
prematurely; abort, or have stillbirths (Swaminathan 2001; Rocourt and Cossart 
1997). 
2.2. Salmonella Typhimurium 
2.2.1 Characteristics of the Organism 
Salmonella enterica ssp. enterica serotype Typhimurium is a gram-
negative, motile, non-spore forming rod, primarily found in the intestinal tract of 
animals. Besides the peptidoglycan layer, gram-negative bacteria, such as S. 
Typhimurium contain an additional lipolysaccharide (LPS) layer that contains 
both polysaccharide and protein linked together in the outer layer, further 
protecting the bacterial cell (D’Aoust et al. 2001; D’Aoust 1997).  
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Salmonella species are organisms that are highly adaptable to extreme 
environmental conditions (D’Aoust et al. 2001). Optimal growth for Salmonella is 
at 37oC and pH range 6.5 to 7.5 with the ability to grow at elevated temperatures 
greater than 54oC and pH values in the range of 4.5 to 9.5 (D’Aoust et al. 2001). 
Growth is inhibited at aw < 0.93 in microbiological media at neutral pH. 
Salmonellae are unable to grow in 3 to 4% NaCl, however they have the ability to 
survive in salt concentrations of up to 30% with increasing temperature (D’Aoust 
et al. 2001). Salmonella are generally easily destroyed by heating to 63oC which 
is the temperature of milk pasteurization. Salmonella Typhimurium DT (definitive 
type) 104 is characterized by its pentaresistance to ampicillin, chloramphenicol, 
streptomycin, sulfonamides and tetracycline.  Additionally, resistance to 
gentamicin, trimethoprim and fluoroquinolones has been observed (D’Aoust et al. 
2001; D’Aoust 1997).   
2.2.2 Sources 
S. Typhimurium is found in the intestinal tract of animals such as birds, 
reptiles, farm animals, humans and some insects. Foods mostly associated with 
the presence of Salmonella spp. are typically of animal origin and include poultry, 
eggs, milk, and beef. The exposure of livestock to environmental sources of 
Salmonella such as contaminated feeds likely has contributed to the persistence 
of Salmonella in the meat industry (D’Aoust et al. 2001). Fruits and vegetables 
that have contacted contaminated soil, water or surfaces are also associated with 
Salmonella. Foods may also be contaminated by improper sanitation of food 
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contact surfaces, i.e., “cross contamination,” as well as through poor hygiene of 
foodservice workers (D’Aoust et al. 2001; D’Aoust 1997).   
2.2.3 Epidemiology of Disease 
According to the CDC, it is estimated that the total number of human 
Salmonella infections in the United States ranges from 800,000 to 4,000,000 
annually with an estimated range of 59,200 to 296,000 of those being S. 
Typhimurium DT104 (Hogue et al. 1997). Of the Salmonella isolates reported to 
the CDC in 1996, approximately 24% were Salmonella Typhimurium (Hogue et 
al. 1997). Salmonella Typhimurium DT104 is now one of the more prevalent 
strains isolated from humans. It was first isolated from humans in the United 
Kingdom in 1984 and became a major cause of salmonellosis in humans in the 
late 1980s. It was first recognized in the United States and elsewhere  in the mid-
1990s. (CDC 2004).  
Salmonella species have numerous virulence factors. These virulence 
factors include those necessary for the organism to adhere to intestinal surfaces, 
to invade the epithelial cells of the host, and the ability to grow and survive in 
phagocytic cells. Salmonella contain greater than 200 virulence factors, and at 
least 60 genes are required for virulence in S. Typhimurium (IFT 2004; D’Aoust 
et al. 2001). Salmonella species use a combination of six adhesins, filamentous, 
hair-like structures or hair-like fimbriae composed of glycoproteins or glycolipids 
on their surfaces that aid in the intestinal colonization by their ability to target 
specific host cell molecules (IFT 2004; D’Aoust et al. 2001). Further, Salmonella 
species have the ability to enter host cells by penetrating the intestinal epithelial 
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barrier. The Type III secretion system, a complex secretion apparatus that 
delivers numerous bacterial proteins into the cytosol of host cells is used by 
Salmonella (IFT 2004; D’Aoust et al. 2001).  The microorganism invades host 
cells by affecting normal cellular processes such as those that control the actin 
cytoskeleton and other signal transduction pathways causing a rearrangement in 
the actin beneath the adherent bacterium. This causes membrane ruffling, 
leading to the engulfment of the bacteria into a membrane-bound vacuole (IFT 
2004; D’Aoust et al. 2001). It is within the vacuole that the bacteria survive and 
reproduce. Salmonella species have an additional Type III secretion system that 
encodes the factors needed for their survival in the intracellular compartment 
formed in the phagocytic cell. Salmonella have virulence plasmids that have 
additional factors, such as the ability to induce lysis, inflammatory responses and 
enteritis in animal hosts, aiding in the extended survival of the bacteria within the 
host cells (IFT 2004; D’Aoust et al. 2001).  
Salmonellosis is the disease caused by Salmonella species. Healthy 
individuals, that are neither immuno-compromised nor pregnant, are less 
susceptible to contracting salmonellosis. At risk groups for disease include the 
elderly, pregnant women and the immuno-compromised. The ingestion of just a 
few cells can cause infection. Symptoms of nausea, vomiting, abdominal pain, 
headache, chills and diarrhea can develop within 12-14 hours of ingestion and 
last for 2-3 days. Other symptoms that can be observed along with above 
symptoms are weakness, faintness, moderate fever, drowsiness and 
restlessness. A mortality rate of 2% to 15% has been observed depending on 
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age of the affected. Approximately 5% of those infected can become carriers of 
the disease (D’Aoust et al. 2001; Jay 2000; D’Aoust 1997).    
2.3 Milk 
2.3.1 Introduction 
The secretion of the mammary gland of female mammals is referred to as 
milk. Milk is typically the only nourishment for young mammals and contains 
components that provide necessary immunological protection. The major 
constituent of milk is water, while the remaining components include fat, lactose, 
and protein (both whey and casein). Smaller quantities of minerals, certain blood 
proteins, enzymes and intermediates of mammary synthesis are also found in 
milk. Each of the components found in milk are important to its structural and 
functional properties. Milk fat is important to flavor and potential off-flavor that 
develop in milk. Proteins bind calcium and stabilize colloidal particles. Lactose 
contributes to osmotic pressure, freezing point depression, and boiling point 
elevation (Singh and Bennett 2002). 
Milk fat and protein composition vary with bovine breed, including Friesian, 
Jersey, Guernsey, Ayrshire, Brown Swiss and Holstein, as well as among 
individual cows within the same herd. This variation in composition is mainly due 
to genetic variation, but can be caused by time of lactation as well as other 
environmental and physiological factors such as type and amount of feed, 
mastitis, weather changes, stress, exhaustion, time of day milking occurs  and 
milking frequency (Singh and Bennett 2002). Following calving, colostrum (the 
first secretion of milk) has a large concentration of fat and protein and low 
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concentration of lactose. Concentrations of these components change to that of 
normal mature milk gradually within two to four weeks (Singh and Bennett 2002).  
2.3.2. Milk Proteins 
Bovine milk contains approximately 3.5% protein which can be separated into 
two main groups—whey and casein (Table 1) (Singh and Bennett 2002). Casein 
can be subdivided into four different proteins:  αs1-, αs2-, β- and κ-casein. 
Caseins which are derived from the actions of native milk proteases are termed 
γ-caseins. All caseins are phosphoproteins with their phosphate groups esterified 
to serine residues within the protein chains. These phosphate groups have the 
ability to bind large quantities of calcium and aid in development of the structures 
of the casein micelles. Of the casein found in normal milk, 95% exists as micelles 
with an average diameter of 150 nm and a range of diameters of 80 to 300 nm. 
There are approximately 1014 casein micelles/ml milk. These micelles are 
approximately 94% protein and 6% colloidal calcium phosphate, which is 
calcium, phosphate, magnesium and citrate (Singh and Bennett 2002).  
The isoelectric point (pI) of casein is at pH 4.6 (Singh and Bennett 2002; 
Swaisgood 1996). Caseins are highly soluble in their native state and heat stable 
at pH > 6. This solubility along with the hydrophobic amino acids covering the 
surface give casein its amphiphilic structure This amphiphilic structure provides 
casein with good emulsifying properties. Hydrophobic residues within the casein 
molecule are not distributed uniformly across the polypeptide chain. The three  
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Table 1. Milk proteins (casein and whey) and their characteristics (Singh and 
Bennett 2002; Swaisgood 1996). 
 % of total milk protein Estimated Average 
MW range (kDa) 
Casein 80  
  αs1-casein 34 23.6 
  αs2-casein 8 25.2 
  β-casein 25 24.0 
  κ-casein 9 19.0 
  γ-casein 4 20.5 
Whey protein 20  
  β-lactoglobulin 9 18.4 
  α-lactalbumin 4 14.2 
  Proteose peptone 4  
  Blood proteins   
  Serum albumin 1 66.3 
  Immunoglobulin 2  
Total 100  
 
hydrophobic regions of αs1-casein are located at residues 1-44, 90-113, and 132-
199 while the two hydrophobic regions of αs2-casein are at segments 90-120 and 
160-207. The C-terminal two-thirds of β-casein is the greatest hydrophobic 
portion of the caseins. The hydrophobic segments of κ-casein are 5-65 and 105-
115. The charged residues are clustered. κ-casein is more polar than αs1-, αs2- 
and β-caseins (Singh and Bennett 2002).  
The remaining soluble proteins found in milk are referred to as whey 
proteins (Singh and Bennett 2002). Whey proteins can be further subdivided into 
α-lactalbumin, β-lactoglobulin, bovine serum albumin (BSA), immunoglobulins 
and proteose peptone (Singh and Bennett 2002; Swaisgood 1996). Whey 
proteins have a net negative charge at pH 6.8, the physiological pH of milk. The 
distribution of hydrophobic, polar and charged residues is uniform in whey 
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proteins. Whey proteins fold intramolecularly, concealing their hydrophobic 
residues, and therefore, do not interact with other proteins. β -lactoglobulin is the 
most abundant whey protein (50%) with a β -barrel structure, similar to the 
structure of a β-sheet but rolled up to form a cylinder, with α-helix on the surface 
and a molecular weight of around 18.0 kDa. With this structure, β-lactoglobulin 
binds with many small hydrophobic molecules. β-lactoglobulin has two disulfide 
bonds in its internal structure and a free single thiol group that account for the 
changes in milk during heating.  Heating causes aggregation due to formation of 
κ-casein-β-lactoglobulin complexes through a disulfide linkage. The second most 
abundant whey protein is α-lactalbumin (20%) with a structure that is compact, 
forming a spherical globular protein and a molecular weight of around 14.0 kDa. 
α-lactalbumin contains four disulfide bonds within the chain which allows for the 
strong binding of two calcium atoms. When these calcium atoms are removed, 
the protein is easily denatured.  Immunoglobulins are the third most abundant 
whey protein (10%) and are antibodies that are created by the presence of 
foreign macromolecular antigens. The fourth most abundant whey protein is 
serum albumin (5%) which is made in the liver and enters milk through the 
secretory cells and appears to function as a carrier of small molecules such as 
fatty acids, but have no known specific role. Other minor components within 
whey proteins are β-microglobulin, lactoferrin, transferrin, protease peptones, 
and acyl glycoproteins (Singh and Bennett 2002; Swaisgood 1996). 
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2.3.3 Antimicrobial Properties 
Milk is not only nutritionally beneficially, but is known to possess 
compounds that may reduce or prevent bacterial growth. For example, in the 
form of colostrum, milk is the first natural defense in the protection and 
development of newborns (Naidu 2000a).  
Lactoferrin, an iron-binding protein found in milk, has antimicrobial 
properties when used at higher concentrations (Law and Reiter 1977; Naidu 
2000b).  The antimicrobial activity of lactoferrin is related to its ability to bind 
essential iron which slows the growth of microorganisms (Law and Reiter 1977), 
to bind directly to the surface of microorganisms (Arnold et al. 1977), or to 
directly damage the outer membrane of gram-negative bacteria releasing 
lipopolysaccharide (Ellison et al. 1988; Ellison et al. 1990). Lactoferricin, or 
pepsin hydrolyzed lactoferrin, provides broad-spectrum activity against various 
bacteria, viruses, fungi and parasites, making it a potent natural antimicrobial 
(Bellamy et al. 1992). At 0.5 to 500 mg/ml, lactoferricin has antimicrobial activity 
against gram-positive and gram-negative bacteria (Bellamy et al. 1992). This 
activity is reduced or eliminated in complex microbiological media and in foods 
(Branen and Davidson 2000).  
Lactoperoxidase, an oxidoreductase and the most abundant enzyme 
secreted in bovine milk, protects the mammary gland as well as the intestinal 
tract of newborns from infection by pathogenic microorganisms (Naidu 2000c). 
Thiocyanate ions and hydrogen peroxide, together with lactoperoxidase compose 
the lactoperoxidase system. It is the through the enzymatic reaction of 
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lactoperoxidase with thiocyanate and hydrogen that provide a broad spectrum of 
activity against bacteria, viruses and fungi (Naidu 2000c).  
Lactoglobulins, or milk-derived immunoglobulins or antibodies, are another 
component which has been examined for its potential to inactivate 
microorganisms. Immunoglobulins can recognize and precipitate bacteria, 
viruses, polysaccharides, nucleotides, peptides and proteins. Colostrum contains 
high levels of these immunoglobulins that provide the primary source of 
protection to the newborn from the mother (Bostwick et al. 2000).  
Lactolipids are another known form of natural antimicrobials found in milk. 
The antimicrobial activity of lipids found in milk is due to the presence of long-
chain unsaturated fatty acids and the medium-chain saturated fatty acids and 
their monoglycerides that act by destabilizing the bacterial membrane by forming 
holes and increasing its porosity (Lampe and Isaacs 2000).  
2.4 Enzymatic Protein Hydrolysis 
Enzymatic protein hydrolysis is the degradation of proteins into peptides 
and/or amino acids by using proteolytic enzymes, such as trypsin and pepsin. 
During protein hydrolysis, peptide bonds are cleaved, and with the addition of 
water, peptides and free amino acids are released (Adler-Nissen 1993). 
Proteolysis is dependent upon the protein substrate, type of proteases used and 
hydrolysis conditions. The sequence of amino acids and the three-dimensional 
structure of the protein affect the ability of the protein to undergo hydrolysis and 
the type of peptides formed during hydrolysis. Enzyme-substrate binding is 
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essential for protein hydrolysis. Globular proteins may be composed of single 
chains or two or more chains which can interact in different ways and are 
spherical in shape (Damodaran 1996). Globular proteins, such as whey protein, 
have most of the peptide bonds within the interior of the protein and, therefore, 
they are inaccessible to the enzyme (Damodaran 1996). Therefore, for 
successful hydrolysis of these proteins, reversible unfolding is necessary in order 
to expose the interior peptide bonds for hydrolysis. Caseins are flexible proteins 
due to their open structure and can be easily hydrolyzed (Swaisgood 1996). 
Hydrolysis of proteins with different amounts of hydrophobic and charged groups 
can result in the formation of peptides varying in their distribution of hydrophobic 
and hydrophilic side groups. 
There are many proteases available for protein hydrolysis and they are 
classified based on their origins (plant, animal, or microbial), mode of action, or 
catalytic site (Adler-Nissen 1993). Endoproteases are enzymes which cleave 
amide bonds within the protein chain. Pepsin and trypsin are examples of 
endoproteases. Pepsin and trypsin are two of the three proteolytic enzymes 
found in the digestive system, the other one being chymotrypsin. Pepsin cleaves 
peptide bonds associated with the aromatic amino acids, phenylalanine, 
tryptophane and tyrosine and is effective in the pH range of 1 to 4. Trypsin 
cleaves bonds associated with the amino acids, lysine and arginine and is 
effective in the pH range of 7 to 9 (Adler-Nissen 1993).    
 The degree of hydrolysis is dependent upon the conditions, temperature, 
pH, enzyme to substrate ratio and reaction time. Temperature, pH and enzyme to 
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substrate ratio determine the rate of the reaction. The reaction time determines 
the final extent of hydrolysis. At low pH, all amino groups are protonated and only 
a portion of carboxyl groups are deprotonated, resulting in an uptake of protons 
for each peptide bond cleaved, increasing the pH. At neutral or alkaline pH, a 
decrease in pH occurs due to the deprotonation of all the carboxyl groups and 
partial protonation of amino groups. In order to prevent these changes in pH in a 
controlled system, a buffer may be used to maintain desired pH (Whitaker 1996).  
 Protein hydrolysis causes the molecular properties of proteins to change 
such as a decrease in molecular weight, an increase in charge, the exposure of 
hydrophobic groups and the exposure of reactive amino acid side chains. As a 
result of these changes, the functional properties may be affected including 
nutritional and physiological. Changes in the nutritional properties of hydrolysates 
include increased digestibility and decreased allergenicity. Smaller peptides are 
easier to digest than whole proteins, which can be beneficial to those people who 
suffer from certain digestive disorders. Further, hydrolysis can be used to destroy 
protein sequences responsible for allergic reactions in those individuals sensitive 
to certain allergens (Damodaran 1996). Physiological properties changed may 
include creation of bioactive peptides (Bellamy et al. 1992; Zucht et al. 1995; 
Recio and Visser 1999), angiotensin converting enzyme (ACE) inhibition (Clare 
and Swaisgood 2000) and opioid activity (Brantl et al. 1979).     
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2.5 Bioactive Peptides from Milk 
2.5.1 Introduction 
Biologically active peptides have been discovered in both animals and 
plants (Gennaro 1989; Lee 1989; Bevins and Zesloft 1990; Lehrer et al. 1993; 
Boman 1995; Cowan 1999; Ganz and Lehrer 1999; Meisel 1997, 1997b, 1998; 
Schanbacher 1997, 1998). Bioactive peptides derived from casein have been 
found to exhibit a variety of biological, physiological, nutritional and antimicrobial 
properties/functions. Bioactive peptides from milk protein hydrolysis include those 
with antimicrobial, opioids, endorphin-like, antihypertensive, decreased blood 
pressure, and antithrombotic, decreased blood clotting properties (Schlimme and 
Meisel 1995; Korhonen et al. 1998; Clare and Swaisgood 2000; Pihlanto-Leppala 
2001). These biologically active peptides have been obtained in vitro by 
proteolysis (Bellamy et al. 1992; Zucht et al. 1995; Recio and Visser 1999) and in 
vivo by gastric digestion of milk proteins (Kuwata et al. 1998; Meisel and 
Bockelmann 1999).  
Casein is a good source of such peptides/protein fragments that have 
these certain physiological functions including aiding in gastrointestinal function 
and digestion, hemodynamic modulation (antihypertension and increased blood 
flow), probiotic support of gut microflora, nonimmune disesase protection, 
passive immunity, immunoregulation, anti- inflammation, growth and 
development (Tome and Debabbi 1998; Schanbacher et al. 1997). Thus, it is 
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important to study the potential for creating peptides through proteolytic 
hydrolysis in vitro which could have antimicrobial activity. 
2.5.2 Opioid Activity 
Peptides derived from the enzymatic digests of casein with opioid activity 
were first reported by Brantl et al. (1979). Peptides with similar activity were 
found by Ziodrou et al. (1979) in the pepsin hydrolysates of α-casein. Bitri (2004) 
found that through a mild acidic hydrolysis using pepsin, imitating gastric-like 
digestion, the release of bioactive material occurred over time. The release of 
material was correlated with acidity rather than enzymatic activity indicating a 
chemical proteolysis produced the protein fragments rather than an enzymatic 
hydrolysis. Biziulevicius et al. (2002) reported on the antimicrobial activity of 
tryptic casein hydrolysate, its mode of antimicrobial action, and its efficacy as a 
treatment and prophylaxis of colibacillus in newborn calves by its stimulation to 
the microbial autolytic system.  
Opioid peptides are short peptides, 5-10 amino acids, and have the ability 
to bind opioid receptors on intestinal epithelial as well as other cells 
(Teschemacher and Koch 1991; Schlimme and Meisel 1995). Opioid peptides 
are derived from β-casein, αs1-casein, β-lactoglobulin, and α-lactalbumin 
(Teschemacher and Koch 1991; Schlimme and Meisel 1995). The major opioid 
peptides are β-casomorphins, which are the 60 to 70 amino acid residues of 
bovine β-casein (Clare and Swaisgood 2000). Opioid peptides are responsible 
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for altering the emptying of gastric contents and decreased intestinal motility 
(Schanbacher et al. 1997; Clare and Swaisgood 2000). 
2.5.3 Immunomodulatory Peptides 
 Immunomodulatory peptides modulate lymphocyte function, lymphocyte 
differentiation, enhance killer cell activity and affect both the immune system and 
cell multiplication responses (Clare and Swaisgood 2000; Schanbacher et al. 
1997). Casein hydrolysates were shown to increase the phagocytic activity of 
human macrophages against red blood cells (Fiat et al. 1989; Jolles et al. 1981; 
Milgliore-Samour et al. 1989). Small peptides at the N-terminal end of bovine α-
lactalbumin and κ-casein increased the multiplication of human peripheral blood 
lymphocytes (Kayser and Meisel 1996).  
2.5.4 Antihypertensive Peptides  
The angiotensin converting enzyme (ACE) is a peptidyldipeptidase that 
cleaves dipeptides from the carboxy terminal end of a protein, and converts 
angiotensin I to angiotensin II, causing an increase in blood pressure (Clare and 
Swaisgood 2000). Peptides can act as ACE inhibitors. True inhibitors are those 
which bind to the active site of ACE without being hydrolyzed by the enzyme. 
Inhibitor peptides can also be substrates of ACE, which can be cleaved by ACE 
releasing new peptides. Those new peptides that are created that yield more 
effective inhibitors are called “pro-drug type inhibitors” while those peptides that 
create less effective inhibitors are called “substrate type inhibitors.” There have 
been numerous peptides and hydrolysates derived from food proteins reported to 
work as ACE inhibitors (Ariyoshi 1993; Meisel and Schlimme 1996; Yamamoto 
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1997; Shah 2000). Hydrolysis with trypsin results in hydrolysates with good ACE-
inhibiting activity (Mullally et al. 1997). ACE inhibition by hydrolysates is mainly 
due to low molecular weight peptides (Meisel et al. 1997; Pihlanto-Leppala et al. 
2000). Casokinins are ACE inhibitors that are derived from the tryptic digestion of 
bovine casein and provide antihypertensive properties (Clare and Swaisgood 
2000). ACE inhibitory peptides have also been created through the hydrolysis of 
αs1-casein and β-casein with Lactobacillus helveticus CP790 (Clare and 
Swaisgood 2000).   
2.5.5 Other Milk Components 
Hydrolysis of the milk components, lactoferrin (Kimura et al. 2000; Kuwata 
et al. 1998; Nibbering et al. 2001; Groenink et al. 1999; Branen and Davidson 
2000; Qian et al. 1995), bovine hemoglobin (Froidevaux et al. 2001), casein 
(Liepke et al. 2001; Lahov and Regelson 1996; Recio and Visser 1999; ), α-
lactoalbumin (Pellegrini et al. 1999) and α-lactoglobulin (Pellegrini et al. 2001) 
and whey (Pihlanto-Leppala 2001) produce hydrolysates with antimicrobial 
activity. Antimicrobial activity of hydrolyzed lactoferrin was observed in peptone 
glucose yeast extract media, but not tryptic soy broth (Branen and Davidson 
2000). When cation and amphipathic peptides were derived from bovine and 
human lactoferrins, those peptides containing the largest number of positively 
charged amino acids showed the greatest antimicrobial activity against both 
gram-positive and gram-negative bacteria (Groenink et al. 1999). Sheep and 
human lactoferrins as well as their pepsin hydrolysates inhibited thrombin-
induced platelet aggregation in a dose dependent manner (Qian et al. 1995). The 
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1-23 fragment of the peptic digest of bovine hemoglobin had low antimicrobial 
activity against Micrococcus luteus A270 (Froidevaux et al. 2001). Pepsin 
hydrolysis of κ-casein (residues 63-117) was found to inhibit growth of gram-
positive bacteria, gram-negative bacteria and yeasts (Liepke et al. 2001). Using a 
heat treatment in combination with the enzyme chymosin, casecidines or 
polycationic low molecular mass peptides with antimicrobial activity were formed 
(Lahov and Regelson 1996). Three bactericidal domains were isolated and 
identified using reversed phase chromatography from bovine α-lactalbumin after 
partial digestion with trypsin and chymotrypsin (Pellegrini et al. 1999) and four 
bactericidal domains were isolated and identified using reversed phase 
chromatography from bovine α-lactoglobulin after digestion with trypsin 
(Pellegrini et al. 2001). Domains derived from both α-lactalbumin and α-
lactoglobulin digesion with trypsin were effective against gram-positive bacteria 
(Pellegrini et al. 2001). Digestion with pepsin created fragments with no 
antimicrobial activity (Pellegrini et al. 1999). However, Recio and Visser (1999), 
using peptic hydrolysis, found two distinct antibacterial domains (183-207 and 
164-179) within the sequence of bovine αs2-casein.  
Known fragments of bovine casein with antimicrobial activity are isracidin 
(Hill et al. 1974), casocidin-I (Zucht et al. 1995), α-casecidins (Otani and Suzuki 
2003), kappacin (Malkoski et al. 2001), and the casein-κ-derived 
glycomacropeptide (Stromqvist et al. 1995; Aniansson et al. 1990). Isracidin is a 
non-immunological polypeptide (with a molecular weight of 2770 Da) obtained 
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from the chymosin digestion of αs1-casein B and consists of the N-terminal 
segment (1-23) of αs1-casein B (Lahov and Regelson 1996). Isracidin was found 
to be significantly effective in vivo at concentrations comparable to antibiotics 
against Staphylococcus aureus strain Smith as well as produced long-term 
immune resistance (Lahov and Regelson 1996).     
 
2.5.6 Antimicrobial mechanism of action 
The mode of action/mechanism of peptide hydrolysates is not fully 
understood. Hydrolysates may affect transmembrane pore-forming mechanisms 
as described for several antimicrobial peptides.  Cationic peptides have been 
shown to kill bacteria by disrupting or permeabilizing the bacterial membrane by 
inducing the uptake of extracellular K+ ions. This uptake of ions leads to the 
depolarization of the outer membrane or, in the case of Gram-negative bacteria, 
permeabilization of the outer membrane. Antimicrobial peptides may accumulate 
at the target membrane surfaces causing displacement of phospholipids leading 
to changes in membrane fluidity and membrane disruption (Yeaman and Yount 
2003). 
It is proposed that the positive charges affect the anionic lipids of the 
bacterial membrane, causing destabilization and destruction of the membrane by 
changing their lipid structure (Kragol et al. 2001). A positive net charge and a 
potentially amphipathic α-helix have been identified as the major structural 
components that interact with the lipid bilayer to enhance the permeability of 
membranes (Dathe et al. 1996).  Dathe et al. (1996) found that amphipathic 
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peptide bound the lipid bilayer at the membrane interface by electrostatic 
interactions between cationic peptide charges and anionic lipid head groups of 
the membrane and through hydrophobic interactions. Peptides with cationic 
amphipathic structures show a high affinity for negatively charged bacterial 
membranes with lipopolysaccharides or anionic phospholipids (Matsuzaki 2001). 
These cationic peptides target the cell surface of the anionic lipids unique to the 
microorganisms (Matsuzaki 2001; Hancock and Lehrer 1998).  
Peptides that are cysteine-rich are thought to form pores or ion-permeable 
channels within the lipid bilayer (Marshall and Arenas 2003). Membrane-active 
peptides that are cationic due to the presence of multiple lysine and arginine 
residues form amphipathic secondary structures which can enter the membrane 
(Matsuzaki 1999).          
. 
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3. Materials and Methods 
3.1 Hydrolysate Preparation 
Whole casein was precipitated at room temperature from 10.8 L of fresh, 
unpasteurized skimmed cow’s milk (Broad Acre Farms, Powell, TN) by the slow 
addition of 300 mL of 2 N HCl to pH 4.6. Precipitated casein was separated by 
centrifugation at 1370 g for 10 min and was subsequently washed by suspending 
in 2.25 L of deionized water followed by recentrifugation. The washing was 
repeated five times. The resulting precipitate was freeze-dried.  
In Method 1, a solution of 1.7 % whole dry casein at pH 2 was incubated 
with pepsin (1:100 w/w) at 37 oC, and a solution of 1.7 % whole dry casein at pH 
8 was incubated with trypsin (1:100 w/w) at 37 oC. After 5 hr, the reaction 
solutions were heated for 5 min at 95 oC to inactivate each enzyme, and rapidly 
cooled to room temperature. The solutions were dialyzed using Spectra/Por® 2 
dialysis membrane (MW cutoff = 12000-14000 Da) (Spectrum Laboratories, Inc., 
Rancho Dominquez, CA) against water for 40 hr with 5 water changes and 
freeze-dried. Solutions containing 0.5% and 1% of each hydrolysate were 
prepared, pH adjusted to ca. 7.0 + 0.2 and filter sterilized through a cellulose 
acetate 0.45 µm membrane filter (Corning Incorporated, Corning, NY). 
In Method 2, a solution of 5.0 % casein was prepared by dissolving whole 
dry casein in 0.1 M pH 7.2 phosphate buffer. The 5.0 % casein solution treated 
similarly to Method 1, however, the hydrolysates created were separated by 
centrifugation at 4000 g for 10 min after inactivation of the enzymes and were not 
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dialyzed against water. The resulting supernatant from centrifugation was pH 
adjusted to ca. 7.0 + 0.2 and filtered sterilized as described in Method 1. 
3.2 Culture Preparation 
Listeria monocytogenes, strains 101, 108, 310 and Scott A and 
Salmonella Typhimurium strains 2380, 2576, 2582 and 2486 were stock cultures 
obtained from microbiology laboratory at the University of Tennessee. All cultures 
were grown in tryptic soy broth (TSB; Difco, Sparks, MD) and transferred every 4 
wk to maintain viability. Working cultures were obtained by inoculating a loopful 
of culture into TSB and incubating for 24 hr at 32oC. Working cultures were 
subsequently transferred every day for 3 days prior to use. After incubation, the 
cultures were diluted to ca. 5.0 log CFU/mL. 
3.3 Micro-broth Dilution Assay 
Sterile 96-well microtiter plates with a well capacity of 300 µL were used 
for all methods. In Method 1, for testing hydrolysate alone, a total volume of 250 
µL was used consisting of 125 µL of double strength TSB, 100 µL of filtered 
hydrolysate and 25 µL of inoculum (ca. 5.0 log CFU/mL). For testing hydrolysate 
in combination with EDTA, a total volume of 250 µL was used consisting of 125 
µL of double strength TSB, 50 µL of filtered hydrolysate (pepsin or trypsin at 0.5 
% and 1 %), 50 µL of EDTA (250 µg/mL EDTA for L. monocytogenes and 1250 
µg/mL for S. Typhimurium DT104) and 25 µL of inoculum (ca. 5.0 log CFU/mL).  
In Method 2, for testing hydrolysate alone, the same method was used as 
in Method 1. However, hydrolysates were tested in combination with either EDTA 
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or sodium lactate and with both EDTA and sodium lactate. For testing 
hydrolysate in combination with either EDTA or sodium lactate, a total volume of 
250 µL was used consisting of 125 µL of double strength TSB, 50 µL of filtered 
hydrolysate (pepsin or trypsin), 50 µL of EDTA (250 µg/mL EDTA for L. 
monocytogenes and 1250 µg/mL for S. Typhimurium DT104) or 50 µL of sodium 
lactate (1 %) and 25 µL of inoculum (ca. 5.0 log CFU/mL). For testing hydrolysate 
in combination with both EDTA and sodium lactate, a total volume of 250 µL was 
used consisting of 125 µL of double strength TSB, 33 µL of filtered hydrolysate 
(pepsin or trypsin), 33 µL of EDTA (250 µg/mL EDTA for L. monocytogenes and 
1250 µg/mL for S. Typhimurium DT104), 33 µL of sodium lactate (1 %) and 25 µL 
of inoculum (ca. 5.0 log CFU/mL).  
For both methods 1 and 2, microtiter plates were covered with a sterile lid 
and incubated 24 hr at 32 oC and the absorbance (630 nm) of each well was 
read at 0, 3, 6, 12, and 24 hr with a microtiter plate spectrophotometer (Elx800 
Universal Microplate reader, BioTek Instruments, Winooski, VT). The micro-broth 
dilution assays for all methods were performed in triplicate. 
3.4 Growth Curve 
In Method 1, pepsin and trypsin hydrolysates (5 %) were mixed with 
bacteria harvested at late logarithmic phase and diluted to ca. 5.0 log CFU/mL. 
The bacteria and hydrolysates were incubated in TSB at 32 oC for 24 hr.  
Bacterial suspensions were enumerated on tryptic soy agar (TSA; Difco) at 0, 3, 
6, 12 and 24 hr. Plates, in duplicate, were incubated for 24 hr at 32 oC. 
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In Method 2, trypsin hydrolysates were mixed with bacteria harvested at 
late logarithmic phase and diluted to ca. 5.0 log CFU/mL. The bacteria and 
hydrolysates were incubated in TSB at 32 oC for 24 hr.  The bacterial 
suspensions were enumerated on TSA at 0, 3, 6, 12 and 24 hr. Plates, in 
duplicate, were incubated for 24 hr at 32 oC. 
3.5 Determination of Protein Content 
The protein concentrations of pepsin and trypsin hydrolysates (before and 
after filtering) in methods was determined using three different protein assays, 
Bradford dye-binding method (Bio-Rad Laboratories, Hercules, CA), modified 
Lowry method (Pierce, Rockford, IL) and UV 280 nm (Chang 1998) . Protein 
concentration determined using the Bradford dye-binding method utilized a 5-
point standard curve that was prepared using bovine serum albumin (BSA), 
ranging from 0.2 to 1 mg protein/mL or a 10-point standard curve also prepared 
using BSA, ranging from 0 to 2 mg protein/mL. To a 50 µL aliquot of unknown or 
standard, 2.5 mL of diluted (1 volume of Dye Reagent Concentrate with 4 
volumes deionized water) and filtered (using Whatman No. 1 paper) Bio-Rad Dye 
Reagent Concentrate was added and the samples were mixed using a vortex. 
The samples were allowed to sit at room temperature for at least 10 min to allow 
for color development. The absorbance was stable for about 1 hr. Each sample 
(unknowns and standards) was transferred to a disposable polystyrene cuvette 
and the absorbance was measured at 595 nm using a UV-VIS scanning 
31 
spectrophotometer (UV-2101PC, Shimadzu, Japan). Protein concentrations of 
the unknown samples were determined using the standard curves. 
In the modified Lowry Protein Assay Kit (Pierce, Rockford, IL), a 10-point 
standard curve was developed using BSA ranging from 0 to 1.5 mg protein/ml. A 
1N Folin-Ciocalteu Reagent was prepared by diluting the 2N reagent 1:1 with 
deionized water. To a 0.2 mL aliquot of unknown or standard, 1.0 mL Modified 
Lowry Reagent (containing cupric sulfate, potassium iodide and sodium tartrate 
in an alkaline solution buffer) was added, mixed well by vortexing and incubated 
for exactly 10 min at room temperature. At the end of the incubation period, 100 
µL of prepared 1N Folin-Ciocalteu Reagent was added, mixed well by vortexing 
and incubated for exactly 30 min at room temperature. Samples (unknowns and 
standards) were transferred to disposable polystyrene cuvettes and the 
absorbance measured at 750 nm. Protein concentrations of the unknown 
samples were determined using the standard curves. 
   For the UV 280 nm method, a 10-point standard curve that was prepared 
with BSA ranging from 0 to 2 mg protein/mL. Each standard and sample were 
transferred to a quartz cuvette and the absorbance at 280 nm measured using a 
UV-VIS spectrophotometer (UNICAM, Cambridge, UK)..The protein 
concentrations of the unknown samples were determined using the standard 
curve.  
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4. Results and Discussion 
4.1. Method 1 
Pepsin and trypsin hydrolysates produced with Method 1 showed little 
antimicrobial activity. Trypsin hydrolysates were slightly effective in extending the 
lag phase and/or reducing the final growth level of three of four strains of Listeria 
monocytogenes (101, 108 and Scott A) (Fig. 1A-D) (all figures located within 
appendix) at 1.0 % (w/v). Trypsin hydrolysates alone or in combination with 
EDTA had no activity against any strain of S. Typhimurium (Fig. 2A-D, 5A-D) at 
up to 1.0. Pepsin hydrolysates were effective in slightly extending the lag phase 
of two of the four strains of L. monocytogenes (101 and 108 at 0.5 %) (Fig. 1B) 
without and with EDTA (3A, 3B) and one of the four strains of S. Typhimurium 
(2486 at 1.0 %) without EDTA (Fig. 2D).  
EDTA alone was effective against one of the four strains of L. 
monocytogenes (101) (Fig. 3A, 4A) and all four strains of S. Typhimurium (2380, 
2576, 2582 and 2486) (Fig. 5A-D, 6A-D) by decreasing the final growth level 
and/or extending the lag phase; however, EDTA had little effect on enhancing the 
inhibitory effect of pepsin or trypsin hydrolysates against either microorganism. 
To more precisely determine the influence of the compounds on growth of 
the test microorganisms, numbers of each were monitored over time (Fig. 7, 8). 
Neither pepsin nor trypsin hydrolysates at 5 % prepared using Method 1 were 
effective in inhibiting the growth of any of the strains of L. monocytogenes (Fig. 
7A-B) or S. Typhimurium (Fig. 8A-B). S. Typhimurium 2486 had decreased 
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growth from 6 to 12 hr; however, there was no decrease in the final level of 
growth as compared to the control (Fig 8B). 
In conclusion, hydrolysate preparation using Method 1 was shown to 
produce solutions that demonstrated little or no inhibition of the test 
microorganisms. The probable reason for this was that low molecular weight 
peptides were lost during dialysis due to the large pore size (MW cutoff = 12000-
14000 Da) in the dialysis tubing. It was theorized that low molecular weight 
peptides are necessary to have antimicrobial activity. This was supported by 
research that showed that peptides from bovine casein and hydrolyzed with 
pepsin and trypsin demonstrated some antimicrobial activity (Miclo et al.. 2001; 
Recio and Visser 1999). Lack of antimicrobial effectiveness may have also been 
due to potential enhancement of bacterial growth due to larger peptides being 
utilized as nutrient sources. 
4.2. Method 2  
4.2.1 Antimicrobial Activity 
 Method 1 was modified to capture the low molecular weight peptides 
proposed to possess the primary antimicrobial activity. By using centrifugation 
instead of dialysis, the smaller molecular weight peptides were captured in the 
supernatant while the larger molecular weight peptides were removed in the form 
of a precipitate.  
 Using Method 2, trypsin hydrolysates were effective in extending the lag 
phase and/or reducing the final growth level of all four strains of L. 
monocytogenes tested (Fig. 9A). However, they were not effective against any of 
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the strain of S. Typhimurium (Fig. 9B). It is suggested that proteolytic digestion of 
bovine casein with trypsin led to the production of several heat stable peptide 
fragments possessing antimicrobial properties. The peptides produced from the 
tryptic digestion of casein displayed greater antimicrobial activity against Gram-
positive bacteria. This would suggest that they may be similar to other cationic 
antimicrobial peptides, such as nisin, which act as surface active compounds 
(Rurh and Sahl 1985). The lack of activity against S. Typhimurium, a Gram-
negative bacterium, was possibly because of the protection afforded to the 
microorganism by the outer membrane which is often effective in screening 
amphiphilic compounds (Matsuzaki 1999). In a similar study, trypsin digestion of 
rabbit casein also did not produce antimicrobial activity against Gram-negative 
organisms (Barayni et al. 2003). 
 Pepsin hydrolysates were not effective in extending the lag phase and/or 
reducing the final growth level of any of the four strains of S. Typhimurium (Fig. 
9D). However, they were effective in reducing the final growth level in L. 
monocytogenes 101 (Fig. 9B). This is contrary to the observations of Baranyi et 
al. (2003) who found that casein-derived peptides isolated from rabbit 
(Oryctolagus cuniculus) milk and digested with chymotrypsin, pepsin and 
clostipain produced several peptide fragments with antimicrobial activity. 
Additionally, Liepke et al. (2001) found that hydrolyzing human milk proteins with 
pepsin produced low-molecular-mass peptide fragments similar to κ-casein that 
increased the antimicrobial activity against Gram-positive, Gram-negative 
bacteria and yeasts. The differences in antimicrobial activity between what we 
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found and those results from Baranyi et al. (2003) and Liepke et al. (2001) most 
probably are due to their increased purification by the previous researchers of 
those compounds responsible for activity. 
 The mechanism of bioactive peptides is thought to be related to their 
ability to increase permeability of the bacterial membrane or other type of 
membrane destabilization (Yeaman and Yount 2003). Therefore, combinations of 
the peptides with traditional, regulatory-approved antimicrobials were tested to 
observe whether or not the inhibition caused by the peptides could enhance 
antimicrobial activity. Method 2 results confirm that trypsin hydrolysates derived 
from bovine milk were effective in extending the lag phase and/or reducing the 
final growth level L. monocytogenes (Fig. 10A-D) and slightly effective in 
reducing the final growth level of S. Typhimurium (Fig. 11A-D). Trypsin 
hydrolysates were found to enhance the antimicrobial activity of sodium lactate 
against L. monocytogenes (Fig. 10A-D) and only slightly enhance the 
antimicrobial activity of sodium lactate against S. Typhimurium (Fig. 11A-D). 
Trypsin hydrolysates derived from bovine milk in combination with EDTA have 
antimicrobial activity against L. monocytogenes and S. Typhimurium in tryptic soy 
broth (TSB) (Fig. 10A-D, 11A-D). However, in this study, the activity was 
primarily due to the presence of EDTA. 
 Pepsin hydrolysates alone showed no antimicrobial activity against either 
L. monocytogenes or S. Typhimurium and did not enhance the antimicrobial 
activity of either sodium lactate or EDTA (data not shown). Branen and Davidson 
(2000) found that pepsin hydrolyzed lactoferrin (HLF) was effective against L. 
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monocytogenes, enterohemorrhagic E. coli and Salmonella Enteritidis in peptone 
yeast extract broth (PYE) but not in TSB. Addition of EDTA enhanced the activity 
of HLF in TSB (Branen and Davidson 2000). In a separate study, Branen and 
Davidson (2004) examined the effect of combining the antimicrobials nisin, 
lysozyme and monolaurin with EDTA and lactoferrin and found that antimicrobial 
activity of certain antimicrobials can be enhanced in combination. For example, 
EDTA enhanced the activity of nisin, monolaurin and lysozyme in TSB against 
two enterohemorrhagic E. coli (Branen and Davidson 2004). Further, while none 
of the antimicrobials alone were bactericidal, in combination with EDTA, nisin, 
lysozyme and monolaurin were bactericidal against some Gram-negative 
bacteria (Branen and Davidson 2004). However, in the present study, addition of 
pepsin or trypsin hydrolysates did not enhance the antimicrobial activity of EDTA 
and lactate against Gram-negative bacteria (Fig. 11A-D).  
Another test was run to determine whether antimicrobial activity could be 
increased by combining both pepsin and trypsin hydrolysates. It was found that 
by adding pepsin hydrolysates, the antimicrobial activity of trypsin hydrolysates 
actually decreased in activity against L. monocytogenes (Fig. 12A-D) and there 
was no effect on the activity against S. Typhimurium (13A-D). 
The Method 2 hydrolysates were evaluated against L. monocytogenes 
and S. Typhimurium  by enumerating the microorganisms over time (Fig. 14 and 
15). Compared to the extent of antimicrobial activity of trypsin hydrolysates 
demonstrated in the spectrophotometric analysis, the activity was reduced using 
the count method (Fig 14A-B, 15A-B). A possible reason for this may be the 
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detection limits of the analysis. The limit of detection of cells using the 
spectrophotometric method is on the order of 5-6 log CFU/mL. In contrast, the 
cell count method used followed growth from 4 log CFU/mL. The lack of increase 
in OD seen in the spectrophotometric assay could be due to the reduced final 
growth level as seen in the count assay. 
It is suggested that activity of the peptide solutions may be enhanced if 
further isolation techniques for the antimicrobial peptides were used. For 
example, it has been found that isolating specific peptide sequences from casein 
that possess antimicrobial activity is important to maximal activity (Malkoski et al. 
2001; Helinck et al. 2003). Malkoski et al. (2001) isolated kappacin, a novel 
antimicrobial peptide from bovine milk and the active form of 
caseinomacropeptide (CMP) consisting of non-glycosylated, phosphorylated κ-
casein (residues 106-169). Malkoski et al. (2001) prepared CMP by chymosin 
digestion of casein and gel-filtration. CMP was effective in inhibiting growth of 
both gram-positive and gram-negative microorganisms. Further, hydrolyzation of 
CMP with endoproteinase Glu-C generated the nonglycosylated peptides 
Ser(P)149 κ-casein-A(138-158) that displayed inhibitory activity in the growth of 
Streptococcus mutans (Malkoski et al. 2001). Recio and Visser (1999) isolated 
and identified two distinct antimicrobial domains from a peptic hydrolysate of 
bovine αs2-casein and determined the C-terminal part of the αs2-casein interacted 
with the cation-exchange membrane used to obtain the antimicrobial fraction. 
Further, in isolating the antibacterial peptides, fragments were found to have 
antimicrobial activity against both Gram-positive and Gram-negative bacteria 
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(Recio and Visser 1999). Otani and Suzuki (2003) isolated cytotoxic peptides, α-
casecidins, from tryptic digestion of bovine αs1-casein and ion-exchange 
chromatography. These peptides were found to be cytotoxic toward all 
lymphocytes examined. The α-casecidins showed little cytotoxic activity towards 
bovine milk cells. Otani and Suzuki (2003) examined the effects of strength of 
charge or cationic peptide on cytotoxic activity and determined no correlation. 
Zucht et al. (1995) found that peptides derived from acid hydrolyzed αs2-casein, 
casocidin-I, demonstrate activity against both gram-positive and Gram-negative 
organisms and further demonstrated that gram-positive microorganisms were 
more sensitive than gram-negative microorganisms. Lahov and Regelson (1996) 
showed that chymosin-hydrolyzed casein and αs1-casein were antimicrobial 
against gram-positive microorganisms in vitro and against Staphylococcus 
aureus in vivo in mice. 
  While it is known that further purification steps to isolate antimicrobial 
peptides from casein are possible, the most useful form of antimicrobials for the 
food industry are crude extracts or preparation (Davidson and Zivanovic, 2003). 
Since casein-derived peptides could provide an alternative or adjunct to 
antimicrobials currently used in foods, further research needs to be conducted to 
find simple methods for enhancing activity by concentrating the hydrolysates or 
isolating and characterizing those peptides with the greatest antimicrobial 
potential. 
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4.2.2 Protein Concentration and Peptide Fragment Determination in 
Method 2 
 A 5 % (w/v) casein (50 mg/mL) starting solution was used for creating 
each type of hydrolysate. Using the Bradford method, non-membrane filtered 
hydrolysates were higher in protein than those that were filtered (84.5 µg/mL vs. 
37.0 µg/mL respectively). Pepsin hydrolysates were higher in protein than trypsin 
hydrolysates in both filtered and non-filtered samples. Average protein 
concentrations for filtered pepsin, non-filtered pepsin, filtered trypsin and non-
filtered trypsin were 62.3 µg/mL, 125.9 µg/mL, 11.7µg/mL and 42.9 µg/mL, 
respectively. The Coomassie brilliant blue dye used in the Bradford method binds 
to primarily basic (arginine groups) and aromatic amino acids (Compton and 
Jones 1985).  
Using the Modified Lowry method, non-filtered hydrolysates were slightly 
higher in protein concentration than those that were filtered (30.4 mg/mL vs. 27.8 
mg/mL respectively). Pepsin hydrolysates were lower in protein concentration 
than trypsin hydrolysates in both filtered and non-filtered samples. Average 
protein concentrations for filtered pepsin, non-filtered pepsin, filtered trypsin and 
non-filtered trypsin were 11.2 mg/mL, 16.0 mg/mL, 44.4 mg/mL and 44.9 mg/mL, 
respectively. The Lowry method applies two reagents, one with Cu2+ which reacts 
with peptide bonds giving a blue color reaction and a second folin cupric reagent 
that reacts with –OH also resulting in a blue color (Lowry et al. 1951). The 
resulting color indicates the amount of small molecular weight peptides.  
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Using the UV 280 nm method, non-filtered hydrolysates were higher in 
protein concentration than those that were filtered (1,680 µg/mL versus 1,500 
µg/mL respectively). Trypsin hydrolysates were higher in protein concentration 
than pepsin hydrolysates in both filtered and non-filtered samples. Average 
protein concentrations for filtered pepsin, non-filtered pepsin, filtered trypsin and 
non-filtered trypsin were 480 µg/mL, 920 µg/mL, 2,180 µg/mL, and 2,450 µg/mL, 
respectively. Just as the Lowry Method, theUV 280 nm determination measures 
smaller sized proteins.  
The actual identity of the peptides isolated from bovine milk casein and 
digested with pepsin and trypsin cannot be discerned from the methods used. 
However, by examining the protein sequence and understanding the method of 
enzymatic cleavage, one can speculate on the peptides formed Fig. (16-19). 
Trypsin cleaves proteins at the amino acids, lysine and arginine. Trypsin 
cleavage of αs1-casein yields 40 different peptide sequences varying in length 
(from one to 41 amino acids) with 28 sequences with 5 amino acids or less (Fig. 
16A). Trypsin cleavage of αs2-casein yields 51 different peptide sequences 
varying in length (from one to 24 amino acids) with 37 sequences with 5 amino 
acids or less (Fig. 17B). Trypsin cleavage of β-casein yields 31 different peptide 
sequences varying in length (from one to  55 amino acids) with 23 sequences 
with 5 amino acids or less (Fig. 17A). Trypsin cleavage of κ-casein yields 27 
different peptide sequences varying in length (from one to 53 amino acids) with 
18 sequences with 5 amino acids or less (Fig 17B).  
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Pepsin cleaves proteins at the amino acids, phenylalanine, tyrosine and 
tryptophan. Pepsin cleavage of of αs1-casein yields 32 different peptide 
sequences varying in length (from one to 58 amino acids) with 24 sequences 
with  5 amino acids or less (Fig. 18A). Pepsin cleavage of αs2-casein yields 33 
different peptide sequences varying in length (from one to  38 amino acids) with 
22 sequences with 5 amino acids or less (Fig. 18B). Pepsin cleavage of β-casein 
yields 29 different peptide sequences varying in length (from one to  32 amino 
acids) with 16 sequences with 5 amino acids or less (Fig. 19A). Pepsin cleavage 
of κ-casein yields 22 different peptide sequences varying in length (from one to 
66 amino acids) with 17 sequences with 5 amino acids or less (Fig 19B). 
Therefore, it was possible that small molecular weight peptides were 
created by the addition of trypsin and pepsin to bovine casein. The possible 
variation in lengths of amino acid sequences created could indicate the varying 
antimicrobial affects from one method to another as well as the variation in 
replications. It appears that trypsin hydrolysates contained a greater quantity of 
small molecular weight peptides which may have contributed to greater 
antimicrobial activity. 
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5. Conclusions 
 Bovine milk contains an assortment of biologically active peptides that can 
be released during enzymatic proteolysis. The primary objective of the food 
industry is to protect consumers from the harmful effects of foodborne 
pathogens. Exploring the potential for use of antimicrobials derived from natural 
sources or bio-based compounds is important in finding alternatives or adjuncts 
to regulatory-approved traditional antimicrobials. The antimicrobial activity of 
traditional antimicrobials may be enhanced by combining them with trypsin or 
pepsin hydrolysates against both Gram-positive and Gram-negative 
microorganisms. Further research will need to be done to characterize and 
identify these “natural” antimicrobial peptides as well as examine their 
effectiveness in food systems. 
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Figure 1. Antimicrobial activity of hydrolysates of acid-precipitated casein, digested with pepsin 
and trypsin, dialyzed and lyophilized (method 1) at 0.5% and 1.0% on Listeria monocytogenes (A) 
101 (B) 108 (C) 310 and (D) Scott A. 
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Figure 2. Antimicrobial activity of acid-precipitated casein digested with pepsin and trypsin, 
dialyzed and lyophilized at 0.5% and 1.0% (method 1) on Salmonella Typhimurium (A) 2380 (B) 
2576 (C) 2582 and (D) 2486. 
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Figure 3. Antimicrobial activity of acid-precipitated casein digested with pepsin, dialyzed and 
lyophilized at 0.5% and 1.0% (method 1) alone and in combination with EDTA against Listeria 
monocytogenes (A) 101 (B) 108 (C) 310 and (D) Scott A. 
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Figure 4. Antimicrobial activity of acid-precipitated casein, digested with trypsin, dialyzed, 
lyophilized at 0.5% and 1.0% (method 1) alone and in combination with EDTA against Listeria 
monocytogenes (A) 101 (B) 108 (C) 310 and (D) Scott A. 
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Figure 5. Antimicrobial activity of acid-precipitated casein digested with trypsin, dialyzed and 
lyophilized at 0.5% and 1.0% (method 1) alone and in combination with EDTA against Salmonella 
Typhimurium (A) 2380 (B) 2576 (C) 2582 and (D) 2486. 
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Figure 6. Antimicrobial activity of acid-precipitated casein, digested with pepsin, dialyzed, 
lyophilized at 0.5% and 1.0% (method 1) alone and in combination with EDTA against Salmonella 
Typhimurium (A) 2380 (B) 2576 (C) 2582 and (D) 2486. 
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Figure 7. Antimicrobial activity of acid-precipitated casein digested with (A) pepsin (B) trypsin, 
dialyzed, lyophilized at 5% against Listeria monocytogenes 108 and 310. 
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Figure 8. Antimicrobial activity of acid-precipitated casein digested with (A) pepsin (B) trypsin, 
dialyzed, lyophilized at 5% against Salmonella Typhimurium 2582 and 2486. 
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Figure 9. Antimicrobial activity of acid-precipitated casein digested with (A) trypsin (B) pepsin, 
centrifuged (method 2) on Listeria monocytogenes and acid-precipitated casein digested with (C) 
trypsin and (D) pepsin, centrifuged (method 2) on Salmonella Typhimurium. 
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Figure 10. Antimicrobial activity of acid-precipitated casein digested with trypsin, centrifuged 
(method 2), and combined with EDTA and sodium lactate on Listeria monocytogenes (A) 101 (B) 
108 (C) 310 and (D) Scott A. 
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Figure 11. Antimicrobial activity of acid-precipitated casein digested with trypsin, centrifuged 
(method 2), and combined with EDTA and sodium lactate on Salmonella Typhimurium (A) 2380 
(B) 2576 (C) 2582 and (D) 2486. 
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Figure 12. Antimicrobial activity of acid-precipitated casein digested with pepsin and trypsin, 
centrifuged (method 2) alone or in combination on Listeria monoctyogenes (A) 101 (B) 108 (C) 
310 and (D) Scott A. 
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Figure 13. Antimicrobial activity of acid-precipitated casein digested with pepsin and trypsin, 
centrifuged (method 2) alone or in combination on Salmonella Typhimurium (A) 2380 (B) 2576 
(C) 2582 and (D) 2486. 
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Figure 14. Antimicrobial activity of acid-precipitated casein digested with trypsin and centrifuged 
(method 2) on (A) Listeria monocytogenes 108 and 310 and (B) Salmonella Typhimurium 2582 
and 2486. 
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Figure 15. Antimicrobial activity of acid-precipitated casein digested with trypsin and centrifuged 
(method 2) on (A) Listeria monocytogenes 101 and Scott A and (B) Salmonella Typhimurium 
2582 and 2486. 
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                  130                   140 
his ser met Lys gln gly ile his ala gln gln Lys glu pro met gly val asn asn gln 
                  150                   160 
glu leu ala typ phe tyr pro glu leu phe arg gln phe tyr gln leu asp ala tyr pro 
                  170                   180 
ser gly ala trp tyr tyr val pro leu gly thr gln tyr thr asp ala pro ser phe ser 
                  190   gly in varient C   199   
asp ile pro asn pro ile gly ser glu asn ser glu Lys thr thre met pro leu trp OH 
(A) 
 
 
1             P P P 11         P         
Lys Asn Thr Met Glu His Val Ser Ser Ser Glu Glu Ser Ile Ile Ser Gln Gln Thr Thr 
21                   31                   
Lys Glu Glu Lys Asn Met Ala Ile Asn Pro Ser Lys Glu Asn Leu Cys Ser Thr Phe Cys 
41                   51         P P P     
Lys Glu Val Val Arg Asn Ala Asn Glu Glu Glu Tyr Ser Ile Gly Ser Ser Ser Glu Glu 
P 62                 71                   
Ser Ala Glu Val Ala Thr Glu Glu Val Lys Ile Thr Val Asp Asp Lys His Tyr Gln Lys 
81                   91                   
Ala Leu Asn Glu Ile Asn Gli Phr Typ Gln Lys Phe Pro Gln Tyr Leu Gln Tyr Lue Tyr 
101                   111                   
Gln Gly Pro Ile Val Leu Asn Pro Trp Asp Gln Val Lys Arg Asn Ala Val Pro Ile Thr 
121               P   P                   
Pro Thr Leu Asn Agr Glu Gln Lue Ser Thr Ser Glu Glu Asn Ser Lys Lys Thr Val Asp 
141   P               151                   
Met Glu Ser Thr Glu Val Phe Thr Lys Lys Thr Lys Leu Thr Glu Glu Glu Lys Asn Arg 
161                   171                   
Leu Asn Phe Leu Lsu Lsy Ile Ser Gln Agr Thr Gln Lys Phe Ala Leu Pro Gln Tyr Leu 
181                   191                   
Lsy Thr Val Tyr Gln His Gln Lys Ala Met Lys Pro Trp Ile Gln Pro Lys Thr Lys Val 
201           207                           
Ile Pro Tyr Val Arg Ttr Leu OH               
(B) 
 
Figure 16. Sequence of amino acids for (A) αs1-casein (B) αs2-casein indicating cleavage at the 
amino acids, lysine (bold) and arginine (underline), using trypsin. 
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pro gln Arg asp met pro ile gln ala phe leu leu tyr gln gln pro va; leu gly pro 
 
 
(B) 
Figure 17. Sequence of amino acids for (A) β-casein (B) κ -casein indicating cleavage at the 
amino acids, lysine (bold) and arginine (underline), using trypsin. 
 
 
 
Arg glu leu glu glu leu asn val pro gly glu ile val glu ser leu ser ser ser glu 
      In G 1 Casein, split here 30         P lys in varient E 40 
glu ser ile thr Arg ile asn Lys Lys ile glu Lys phe gln ser glu glu gln gln gln 
                  50       In varient C, lys     60 
thr glu asp glu leu gln asp Lys ile his pro phe ala gln thr gln ser leu val tyr 
  In varients B, A1 & C his     70                   80 
pro phe pro gly pro ile pro asn ser leu pro gln asn ile pro pro leu thr gln pro 
                  90                   100 
pro val val val pro pro phe leu gln pro glu val met Lys val ser Lys val Lys glu 
In G 3 Casein, split here   Split here in G 2 Casein                 120 
ala met ala pro Lys his Lys glu met pro phe pro Lys tyr pro val gln pro phe thr 
  arg in varient B         130                   140 
glu ser gln ser leu thr leu thr asp val glu asn leu his leu pro pro leu leu leu 
                  150                   160 
gln ser trp met his gln pro his gln pro leu pro pro thr val met phe pro pro gln 
                  170                   180 
ser val leu ser leu ser gln ser Lys val leu pro val pro glu Lys ala val pro tyr 
                  190                   200 
pro gln Arg asp met pro ile gln ala phe leu leu tyr gln gln pro va; leu gly pro 
         209           
val Arg gly asp met phe pro ile ile val OH          
                  190                   200 
                    
(A) 
 
 
 
1          11          
Glu Glu Gln Asn Gln Glu Gln Pro Ile Arg Cys Glu Lys Asp Glu Arg Phe Phe Ser Asp 
21                   31                   
Lys Ile Ala Lys Tyr Ile Pro Ile Gln Tyr Val Leu Ser Arg Tyr Pro Ser Tyr Gly Leu 
41                  51                 
Asn Tyr Tyr Gln Gln Lys Pro Val Ala Leu Ile Asn Asn Gln Phe Lue Pro Tyr Pro Tyr 
61                   61                   
Tyr Ala Lys Pro Ala Ala Val Arg Ser Pro Ala Gln Ile Leu Gln Trp Gln Val Leu Ser 
81                   81                   
Asp Thr Val Pro Ala Lys Ser Cys Gln Ala Gln Pro Thr Thr Met Ala Arg His Pro His 
101       105 106         111                   
Pro His Leu Ser Phe Met Ala Ile Pro Pro Lys Lys Asn Gln Asp Lys Thr Glu Ile Pro 
121                   131       Ile Varient B     
Thr Ile Asn Thr Ile Ala Ser Gly Glu Pro Thr Ser Thr Pro Thr Thr Glu Ala Val Glu 
141       Varient B has Ala P   151                   
Ser Thr Val Ala Thr Leu Glu Asp Ser Pro Glu Val Ile Glu Ser Pro Pro Glu Ile Asn 
161               169                       
Thr Val Gln Val Thr Ser Thr Ala Val            
70 
 
arg pro lys his pro ile lys his gln gly leu pro gln (glu val leu asn glu asn leu 
(Absent in Varient A) 30                   40 
leu arg Phe Phe val ala) pro Phe pro gln val Phe gly lys glu lys val asn glu leu 
          P   P   50     ThrP in varient D   60 
ser lys asp ile gly ser glu ser thr glu asp gln ala met glu asp ile lys glu met 
      P   P P P 70         P         80 
glu ala glu ser ile ser ser ser glu glu ile val pro asn ser val glu gln lys his 
                  90                   100 
ile gln lys glu asp val pro ser glu arg Tyr leu gly Tyr leu glu gln leu leu arg 
                  110         P         120 
leu lys lys Tyr lys val pro gln leu glu ile val pro asn ser ala glu glu arg leu 
                  130                   140 
his ser met lys gln gly ile his ala gln gln lys glu pro met gly val asn asn gln 
                  150                   160 
glu leu ala typ Phe Tyr pro glu leu Phe arg gln Phe Tyr gln leu asp ala Tyr pro 
                  170                   180 
ser gly ala Trp Tyr Tyr val pro leu gly thr gln Tyr thr asp ala pro ser Phe ser 
                  190   gly in varient C   199   
asp ile pro asn pro ile gly ser glu asn ser glu lys thr thre met pro leu Trp OH 
(A) 
1             P P P 11         P         
Lys Asn Thr Met Glu His Val Ser Ser Ser Glu Glu Ser Ile Ile Ser Gln Gln Thr Thr 
21                   31                   
Lys Glu Glu Lys Asn Met Ala Ile Asn Pro Ser Lys Glu Asn Leu Cys Ser Thr Phe Cys 
41                   51         P P P     
Lys Glu Val Val Arg Asn Ala Asn Glu Glu Glu Tyr Ser Ile Gly Ser Ser Ser Glu Glu 
P 62                 71                   
Ser Ala Glu Val Ala Thr Glu Glu Val Lys Ile Thr Val Asp Asp Lys His Tyr Gln Lys 
81                   91                   
Ala Leu Asn Glu Ile Asn Gli Phr Typ Gln Lys Phe Pro Gln Tyr Leu Gln Tyr Lue Tyr 
101                   111                   
Gln Gly Pro Ile Val Leu Asn Pro Trp Asp Gln Val Lys Arg Asn Ala Val Pro Ile Thr 
121               P   P                   
Pro Thr Leu Asn Agr Glu Gln Lue Ser Thr Ser Glu Glu Asn Ser Lys Lys Thr Val Asp 
141   P               151                   
Met Glu Ser Thr Glu Val Phe Thr Lys Lys Thr Lys Leu Thr Glu Glu Glu Lys Asn Arg 
161                   171                   
Leu Asn Phe Leu Lsu Lsy Ile Ser Gln Agr Thr Gln Lys Phe Ala Leu Pro Gln Tyr Leu 
181                   191                   
Lsy Thr Val Tyr Gln His Gln Lys Ala Met Lys Pro Trp Ile Gln Pro Lys Thr Lys Val 
201           207                           
Ile Pro Tyr Val Arg Ttr Leu OH               
(B) 
Figure 18. Sequence of amino acids for (A) αs1-casein (B) αs2-casein indicating cleavage at the 
amino acids, phenylalanine (bold), tyrosine (italics) and trytophan (underline) using pepsin. 
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(B) 
Figure 19. Sequence of amino acids for (A) β-casein (B) κ-casein indicating cleavage at the 
amino acids, phenylalanine (bold), tyrosine (italics) and trytophan (underline) using pepsin. 
arg glu leu glu glu leu asn val pro gly glu ile val glu ser leu ser ser ser glu 
      In G 1 Casein, split here 30         P lys in varient E 40 
glu ser ile thr arg ile asn lys lys ile glu lys Phe gln ser glu glu gln gln gln 
                  50       In varient C, lys     60 
thr glu asp glu leu gln asp lys ile his pro Phe ala gln thr gln ser leu val Tyr 
  In varients B, A1 & C his     70                   80 
pro Phe pro gly pro ile pro asn ser leu pro gln asn ile pro pro leu thr gln pro 
                  90                   100 
pro val val val pro pro Phe leu gln pro glu val met lys val ser lys val lys glu 
In G 3 Casein, split here   Split here in G 2 Casein                 120 
ala met ala pro lys his lys glu met pro Phe pro lys Tyr pro val gln pro Phe thr 
  arg in varient B         130                   140 
glu ser gln ser leu thr leu thr asp val glu asn leu his leu pro pro leu leu leu 
                  150                   160 
gln ser Trp met his gln pro his gln pro leu pro pro thr val met Phe pro pro gln 
                  170                   180 
ser val leu ser leu ser gln ser lys val leu pro val pro glu lys ala val pro Tyr 
                  190                   200 
pro gln arg asp met pro ile gln ala Phe leu leu Tyr gln gln pro va; leu gly pro 
                209                       
val arg gly pro Phe pro ile ile val OH                     
 
                    
                    
         (A)           
                    
                    
1                   11                   
Glu Glu Gln Asn Gln Glu Gln Pro Ile Arg Cys Glu Lys Asp Glu Arg Phe Phe Ser Asp 
21                   31                   
Lys Ile Ala Lys Tyr Ile Pro Ile Gln Tyr Val Leu Ser Arg Tyr Pro Ser Tyr Gly Leu 
41                   51                   
Asn Tyr Tyr Gln Gln Lys Pro Val Ala Leu Ile Asn Asn Gln Phe Lue Pro Tyr Pro Tyr 
61                  71                   
Tyr Ala Lys Pro Ala Ala Val Arg Ser Pro Ala Gln Ile Leu Gln Trp Gln Val Leu Ser 
81                   91                   
Asp Thr Val Pro Ala Lys Ser Cys Gln Ala Gln Pro Thr Thr Met Ala Arg His Pro His 
101       105 106         111                   
Pro His Leu Ser Phe Met Ala Ile Pro Pro Lys Lys Asn Gln Asp Lys Thr Glu Ile Pro 
121                   131       Ile Varient B     
Thr Ile Asn Thr Ile Ala Ser Gly Glu Pro Thr Ser Thr Pro Thr Thr Glu Ala Val Glu 
141       Varient B has Ala P   151                   
Ser Thr Val Ala Thr Leu Glu Asp Ser Pro Glu Val Ile Glu Ser Pro Pro Glu Ile Asn 
161               169                       
Thr Val Gln Val Thr Ser Thr Ala Val            
72 
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